OOIR: Observatory of International Research

Papers

(The median citation count of American Heart Journal is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Association of Increased Fructose Consumption with Atrial Fibrillation Symptoms	214
Differences in Clinical Outcomes Between Non-Obese Caucasian and African American Populations Who Have Diabetes, A Nation-Wide Study	188
Table of Contents	101
Table of Contents	97
Possibilities of Screening and Intervention Strategies in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus with the Risk of HF	91
Editorial Board	74
Arrhythmia Risk in Non-Obese versus Obese Patients with Psoriatic Arthritis and Type 2 Diabetes	66
Impact of NT-proBNP Levels on Clinical Outcomes in Peripartum Cardiomyopathy: A Propensity-Matched Analysis Using the TriNetX Research Network	57
Tirzepatide vs Semaglutide in Coronary Artery Disease and Obesity: Real-World Cardiovascular Outcomes Analysis from the TriNetX Research Network	55
Information for Readers	44
Accuracy of Diagnosing Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), and DKA-HHS: The Significance for Cardiac Function	41
The trial to assess chelation therapy 2 (TACT2): Rationale and design	39
Malignant left ventricular hypertrophy and risk of cognitive impairment in SPRINT MIND trial	38
Non-Adherence to Antihypertensive Medications Among the US Population: A Pooled Analysis of 22 Million Patients	38
Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER	35
Information for Readers	35
Rationale and design of NUDGE-CKD: A nationwide randomized factorial trial of electronic nudges for increasing guideline-directed medical therapy in chronic kidney disease	33
Heart failure and nocturnal hypoxemic burden, the connection is getting closer and closer	33
COMPARE LAAO: Rationale and design of the randomized controlled trial “COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at hig	31
Cardiac auscultation skills among medical trainees	31
Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake (NUDGE-FLU): Study protocol for a nationwide randomized implementation trial	30
Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: Study protocol for a multi-center, prospective, randomized, open-label, blinded e	30
Risk of delayed percutaneous coronary intervention for STEMI in the Southeast United States	30
Differences in incident and recurrent myocardial infarction among White and Black individuals aged 35 to 84: Findings from the ARIC community surveillance study	29
The rationale, design, and methods of a trial to evaluate the efficacy and safety of oxygen therapy in patients with intermediate-risk acute pulmonary embolism	28

Rationale and design of the NODE-303 study: evaluating the safety of symptom-prompted, self-administered etripamil for paroxysmal supraventricular tachycardia episodes in real-world settings	28
Accuracy of instantaneous wave-free ratio and fractional flow reserve derived from single coronary angiographic projections	28
Rationale and study design of the GOREISAN for heart failure (GOREISAN-HF) trial: A randomized clinical trial	27
Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial	26
Democracy, healthcare, and the public good	26
Evaluation of Huawei smart wearables for detection of atrial fibrillation in patients following ischemic stroke: The Liverpool-Huawei stroke study	26
Physician responses to apple watch-detected irregular rhythm alerts	26
Absence of coronary artery disease in patients undergoing coronary imaging and association with amyloidosis: A Danish nationwide study	26
Table of Contents	25
Cardiovascular Outcomes in Type 2 Diabetes Patients with Inflammatory Polyarthropathy: SGLT2 Inhibitors versus GLP-1 Receptor Agonists	25
Ambulatory inotropic therapy: To what end?	25
Diagnostic performance of a novel automated CT-derived FFR technology in detecting hemodynamically significant coronary artery stenoses: A multicenter trial in China	25
Information for Readers	25
Response to the letter: Time alignment considerations in evaluating AI-ECG guidance of pulmonary valve replacement timing in repaired tetralogy of Fallot	25
Rheumatoid Arthritis and the Connection with Cardiovascular Disease Mortality	24
Longer term benefits of exercise and escitalopram in the treatment of anxiety in patients with coronary heart disease: Six month follow-up of the UNWIND randomized clinical trial	24
Obicetrapib Does Not Accumulate in Adipose Tissue: Results from Studies in Man and Non-Human Primates	23
Clinical Data and Diagnostic findings in Patients with Ischemic Heart Disease undergoing Coronary Angiography: a Cross-sectional study from a Tertiary Hospital in Sudan, Africa	23
Single Nucleotide Variants of the MCM6 Gene as a Risk Factor for Metabolically Unhealthy Obesity in Children	23
Impact of moderate or severe mitral and tricuspid valves regurgitation after transcatheter aortic valve replacement	22
Implementing remote patient monitoring to improve hypertension control in a primary care network: Rationale and design of the monitor-BP Cluster Randomized Trial	22
Prehospital treatment with zalunfiban (RUC-4) in patients with ST‐ elevation myocardial infarction undergoing primary percutaneous coronary intervention: Rationale and design of the CELEBRATE trial	22
A Bayesian re-analysis of the STRESS trial	21
Enhancing risk stratification for incident systolic heart failure through machine learning and natural language processing	21
Premorbid physical activity and prognosis after incident myocardial infarction: The atherosclerosis risk in communities study	21
Catheter-based left atrial appendage CLOSURE in patients with atrial fibrillation at high risk of stroke and bleeding as compared to best medical therapy: Rationale and design of the prospective rando	20
Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey	20
Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry	20
The European Bifurcation Club randomised trial of stepwise provisional stenting versus Drug Coated Balloon therapy for non-left main true coronary bifurcations: The EBC DCB Trial	20
Lipoprotein(a) immunoassays and their associations with coronary artery calcification and aortic valve calcification	20
Rationale and design of the Dynamic Coronary Roadmap for Contrast Reduction (DCR4Contrast) in PCI randomized controlled trial	20
Shortening the duration of dual antiplatelet therapy after percutaneous coronary intervention for acute coronary syndrome: A systematic review and meta-analysis	19
Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinica	19
Rationale and design of BROKEN-SWEDEHEART: a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome	18
Implementing guideline-directed medical therapy: Stakeholder-identified barriers and facilitators	18
Pursuing functional biomarkers in complex disease: Focus on pulmonary arterial hypertension	18
Prospective randomized comparison between upgraded ‘2C3L’ vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial design	18
The incremental role of late gadolinium enhancement in risk stratifying high risk patients with hypertrophic cardiomyopathy	18
The pediatric heart network's study on long-term outcomes of children with HLHS and the impact of Norwood Shunt type in the single ventricle reconstruction trial cohort (SVRIII): Design and adaptation	18
Diversity of electrocardiographic patterns in left main culprit acute ST-elevation myocardial infarction	18
Editorial Board	17
Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial	17
Adipose tissue n-3/n-6 fatty acids ratios versus n-3 fatty acids fractions as predictors of myocardial infarction	17
Editorial Board	17
Relationship between left atrial stiffness, pulmonary congestion, and impaired aerobic capacity in adults with repaired coarctation of aorta	17
Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in is	17
GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: Cardiovascular Outcomes and Mortality Benefits	17
Encouraging the prescribing of SGLT2i and GLP-1RA medications to reduce cardiovascular and renal risk in patients with type 2 diabetes: Rationale and design of a randomized controlled trial	17
Chest pain and coronary artery disease in cardiac amyloidosis: Prevalence, mechanisms, and clinical implications	17
Differences in guideline directed medical therapy for rural and non-rural Veterans with heart failure with reduced ejection fraction	17

Trends in outcomes and resource utilization for acute myocardial infarction admissions during the COVID-19 pandemic	16
Results from a Randomized, Open-Label, Crossover Study Evaluating Pharmacokinetic Interaction Between the Aldosterone Synthase Inhibitor Baxdrostat and Metformin in Healthy Human Subjects	16
Development of a unified national database of primary percutaneous coronary intervention centers with co-located emergency departments, 2020	16
Information for Readers	16
Impact of a clinical atrial fibrillation risk estimation tool on cardiac rhythm monitor utilization following acute ischemic stroke: A prepost clinical trial	16
Prognostic impact of quantitative flow ratio (QFR)-consistent complete revascularization in patients with myocardial infarction and multivessel coronary artery disease	16
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria	16
ISCHEMIA-EXTEND studies: Rationale and design	16
Gamification-augmented home-based exercise for peripheral artery disease: Rationale and design of the GAMEPAD Study	16
Efficacy of Liraglutide Versus Gliclazide in Treatment of Patients with Type II Diabetes Mellitus: Systematic Review and Meta-Analysis	16
Corrigendum to ``Transcoronary cooling and dilution for cardioprotection during revascularisation for ST-segment elevation myocardial infarction: design and rationale of the STEMI-Cool study''. [Am He	16
Inflammation biomarkers and incident coronary heart disease: the Reasons for Geographic And Racial Differences in Stroke Study	16
Perioperative bleeding and outcomes after noncardiac surgery	15
Effect of colchicine on progression of known coronary atherosclerosis in patients with STable CoROnary artery disease CoMpared to placebo (EKSTROM) trial—rationale and design	15
Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis	15
Cardiovascular Regulatory Science: Accelerating the Path from Bench to Bedside	15
Editorial Board	15
Neonatal outcomes of pregnancy in women with congenital heart disease	15
The effects of low-dose colchicine on the progression of aortic valve stenosis: Rationale, design, and baseline characteristics of the Colchicine and Inflammation in Aortic Stenosis (CHIANTI) trial	15
Clinical Outcomes in Non-Obese Caucasian and Hispanic Populations with DM, a Nation-Wide Study	15
Prediabetes in Takotsubo Syndrome: Impact on Cardiovascular Outcomes and Mortality in a Propensity-Matched Cohort Study	14
Information for Readers	14
Estimate Patient's 10-Years Cardiovascular Risk using Arteriosclerotic Cardiovascular Disease Tool a Cross-Sectional Study in Al-Harja, Asser, Saudi Arabia, 2021	14
Benefits of Fiber-Rich Snacks on Waist Circumference and Atergenic Index of Plasma in Obese	14
Deploying a novel custom mobile application for STEMI activation and transfer in a large healthcare system to improve cross-team workflow. STEMIcathAID implementation project	14
Familial Hypercholesterolemia and Type 2 Diabetes: Diagnostic and Therapeutic Challenges	14
Patient characteristics, treatment patterns, and prognosis in drug-use-associated infective endocarditis in Denmark from 1999 to 2018	13
Complete revascularization in patients with acute myocardial infarction and multivessel disease: Pooled analysis of Kaplan-Meier-derived individual-patient-data	13
Pragmatic trial of messaging to providers about treatment of acute heart failure: The PROMPT-AHF trial	13
Mortality and rehospitalization after mitral valve surgery as a function of age and key comorbidities	13
Towards a person-centered after-visit summary to facilitate improved heart failure care (HF-AVS): A scoping review and call to action	13
Rationale and design of the direct oral anticoagulants for prevention of left ventricular thrombus after anterior acute myocardial infarction (APERITIF) trial	13
The Role of Dialysis in Outcomes of LVAD Implantation in Chronic Kidney Disease Patients: Insights from US National Readmission Database	13
Early oral anticoagulation monotherapy after PCI: Insights from the POEM trial	13
Plasma proteomics for prediction of subclinical coronary artery calcifications in primary prevention	13
Association of change in QRS duration with chronic heart failure outcomes	13
Advancement of the implementation of evidence-based therapies for cardiovascular-kidney-metabolic conditions: A multi-stakeholder perspective	13
Influence of left ventricular ejection fraction in patients undergoing contemporary pLVAD-supported high-risk PCI	13
Design and rationale of a pragmatic randomized clinical trial of early dronedarone versus usual care to change and improve outcomes in persons with first-detected atrial fibrillation – the CHANGE AFIB	13
Framework of the strengths and challenges of clinically integrated trials: An expert panel report	13
Surrogate markers of gut dysfunction are related to heart failure severity and outcome–from the BIOSTAT-CHF consortium	13
Patterns of diuretic titration during inpatient management of acute decompensated heart failure	13
Tailored hydration for the prevention of contrast-induced acute kidney injury after coronary angiogram or PCI: A systematic review and meta-analysis	13
Complete revascularization versus culprit-lesion only PCI in patients with NSTEMI and multivessel disease – Design and rationale of the randomized COMPLETE-NSTEMI trial	12
Editorial Board	12
Dyslipidaemia Patterns and Risk Factors Among Patients with Diabetes, Hypertension, and Both Diabetes and Hypertension at a Tertiary Hospital in Malawi	12
Transcatheter aortic‐valve implantation with or without on‐site cardiac surgery: The TRACS trial	12
Rationale and design of the early valve replacement in severe asymptomatic aortic stenosis trial	12
Anatomic and physiologic classification of adults with congenital heart disease to predict adverse outcomes: Use of administrative codes compared to clinical staging	12
Potassium-competitive acid blocker vs proton-pump inhibitor in patients receiving antithrombotic therapy who are at high risk for gastrointestinal bleeding: Rationale and design of the randomized PROT	12
Association of testosterone-induced increase in neutrophil and monocyte counts with thromboembolic events: The TRAVERSE trial	12
Distinct triglyceride-glucose trajectories are associated with different risks of incident cardiovascular disease in normal-weight adults	12
Danish-German cardiogenic shock trial—DanGer shock: Trial design update	12
Bempedoic Acid for Management of Dyslipidemia from an Indian Perspective: An Expert Consensus Report	12
Prognostic value of echocardiography for heart failure and death in adults with chronic kidney disease	12
Strategy to optimize PeriproCeduraL AnticOagulation in structural transseptal interventions: Design and rationale of the STOP CLOT trial	12
Prognostic Value of Triglyceride-Glucose Index for the Prediction of Cardiovascular Events: Results from the Multi-Ethnic Study of Atherosclerosis (MESA)	12
Table of Contents	12
Physician assessment of aortic stenosis severity, quantitative parameters, and long-term outcomes: Results from the KP-VALVE project	12
Editorial Board	12
Association between visit frequency, continuity of care, and pharmacy fill adherence in heart failure patients	12
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure	12
Extra-virgin olive oil and additional cardiovascular outcomes in the PREDIMED Trial: An outcome-wide perspective	12
Direct His/LBB Pacing as an Alternative to Biventricular Pacing in Patients With HFrEF and a Typical LBBB. Design and rationale for the His-alternative II trial	12
Sex-differences in 5 year Survival with Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Graft surgery in patients with Diabetes and Multivessel Disease	12
Comparative effectiveness and healthcare utilization for ambulatory cardiac monitoring strategies in Medicare beneficiaries	12
The Effect of Avocado Drink (Persea Americana Mill) on the Incidence of Ballooning Hepatocyte in the Liver Organs of Rats (Rattus Novergicus) Induced by Hypercholesterolemia	11
Editorial Board	11
Proportion of Obesity-Related Conditions Attributable to Obesity in US Adolescents and Young Adults	11
OCEAN trial update	11
Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE): Rationale and design	11
Trends in urine drug screening and positivity among patients with heart failure: Insights from a large health system	11
Editorial Board	11
Self-Medication Practices from the Perspective of Tunisian Cardiovascular Patients – A Community Pharmacy-Based Survey	11
Information for Readers	11
Precision Profiling of Advanced CVD and CKM Syndrome Through Lipidomics and Immunophenotyping	11
Use of e-cigarettes, traditional combustible cigarettes, and high sensitivity C-reactive protein: The Cross Cohort Collaboration	11
Race, hypertensive disorders of pregnancy and outcomes in peripartum cardiomyopathy	11
Accurate Fick cardiac output estimation: direct and simultaneous oxygen consumption measurement is imperative in heart failure	11
Relationship Between Vaccines Against Coronavirus Disease 2019 (Covid-19) and Myocarditis	11

Table of Contents	11
Cardiovascular Risk in Obstructive Sleep Apnea: Impact of Glycemic Control in Diabetes — Insights from the TriNetX Network	11
Risk Scale for Patients with Newly Diagnosed Diabetic Foot Ulcer - Which Patients May Experience Healing Failure or Need Revascularization	11
Study protocol and baseline characteristics of Randomized trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid: RESPECT-EPA, the combination of	11
Rate versus rhythm control in patients with newly diagnosed atrial fibrillation: Effects of the treatment timing on health status outcomes	11
Rationale and design of European microcirculatory resistance and absolute flow team: The Euro-CRAFT registry	11
Effects of complete revascularization according to age in patients with ST-segment elevation myocardial infarction and multivessel disease (COMPLETE-AGE)	10
On-treatment blood pressure and cardiovascular mortality in adults with repaired coarctation of aorta	10
Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet	10
Investigating the Smoker's Paradox: Aortic Stenosis Patient Outcomes in Smokers	10
Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia	10
Enhancing cardiac rehabilitation adherence through home-based rehabilitation and behavioral nudges: The ERA nudge study design and rationale	10
The effect of tablet computer-based telemonitoring added to an established telephone disease management program on heart failure hospitalizations: The Specialized Primary and Networked Care in Heart F	10
Effect of tirzepatide on the progression of coronary atherosclerosis using MDCT: Rationale and design of the tirzepatide treatment on coronary atherosclerosis progression: The (T-Plaque) randomized-co	10
Lactate Dehydrogenase can be Considered a Predictive Marker of Severity and Mortality of Covid-19 in Diabetic and Non-Diabetic Patients. A Case Series	10
Overview of 2024 FDA Advisory Panel Meeting on the TriClip transcatheter tricuspid valve repair system	10
Table of Contents	10
Does targeted positioning of the left ventricular pacing lead towards the latest local electrical activation in cardiac resynchronization therapy reduce the incidence of death or hospitalization for h	10
Editorial Board	10
Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial	10
Design of VICTORION-2 Prevent: a randomized double-blind, placebo-controlled trial, assessing the impact of inclisiran on major adverse cardiovascular events in patients with established cardiovascula	10
Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions	10
Mavacamten in symptomatic adolescent patients with obstructive hypertrophic cardiomyopathy: design of the phase 3 SCOUT-HCM trial	10
Design and rationale of the HD PCI trial: A cluster randomized crossover trial of higher vs. lower dose heparin for elective percutaneous coronary intervention	10
Transcatheter edge-to-edge repair for chronic functional mitral regurgitation in patients with very severe left ventricular dysfunction	10
Transcatheter or surgical aortic valve replacement in patients with severe aortic stenosis aged 70 years or younger: A NOTION-2 substudy	10
Single Nucleotide Variants of the VDR Gene and Cardiometabolic Risk in Obesity	10
Meta‐analysis assessing the sensitivity and specificity of 18F‐FDG PET/CT for the diagnosis of prosthetic valve endocarditis (PVE) using individual patient data (IPD)	10
Associations between practice-level compliance with cardiac performance measures and clinical outcomes in US cardiovascular ambulatory care	10
A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) – design and rationale of the left ventricular unloading trial domain	10
Comparing the outcomes of rheumatic heart disease in pregnancy complicated with and without atrial fibrillation: A propensity score matched analysis	9
Obicetrapib Alone and in Combination with Ezetimibe Reduces Atherosclerotic Lesion Prevalence, Size and Severity in ApoE*3-Leiden.CETP Mice	9
Incorporating Ensembled Stacked Approach into Automated Machine Learning in an Attempt to Predict Acute Ischemic Heart Disease in Patients with Atypical Chest Pain: Secondary Analysis of a Single-Cent	9
Table of Contents	9
Design, rationale, and characterization of the mobile health based occupational cardiovascular risk intervention study (mHealth-OPEN study)	9
Prognosis of Hospitalizations of Patients with Different Phenotypes of Heart Failure in Type 2 Diabetes Mellitus	9
Information for Readers	9
Contemporary laboratory assessment of acute cardiorenal syndrome for early diagnosis: A call for action	9
Central Venous Access: Conventional Seldinger Versus Ultrasound-Guided Technique to Reduce Associated Complications in A School Hospital	9
Predictors of Major Adverse Limb Events After Infrainguinal Bypass in Patients with Diabetes	9
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trials	9
Adiponectin as a Biomarker for Subclinical Atherosclerosis in Obese Adults with Type 2 Diabetes Mellitus	9
Comparative Cardiovascular Outcomes Between Carvedilol and Metoprolol in Patients with Takotsubo Syndrome: A Propensity-Matched Cohort Study	9
The Use of Extracorporeal Membrane Oxygenation (ECMO) and Protective Mechanical Ventilation in the Treatment of Acute Respiratory Failure	9
Editorial Board	9
Prognosis of patients with nonspecific electrocardiogram findings in a Tanzanian emergency department	9
Effect of opt-in versus opt-out framing on trial recruitment: a study within a trial of the GAMEPAD randomized trial	9
Rationale and design of the multicentric randomized EVAOLD trial: Evaluation of a strategy guided by imaging versus routine invasive strategy in elderly patients with ischemia	9
Association Between Glycemic Control and Adverse Outcomes in Atrial Fibrillation: Evidence from a Large Real-World Cohort	9
Prediction of early death after atrial fibrillation diagnosis using a machine learning approach: A French nationwide cohort study	9
Pregnancy in women with congenital heart disease: New insights into neonatal risk prediction	9
Hospital-level variation in cardiac rehabilitation metrics	8
Baseline NT-proBNP nonresponse score and health status measures in assessing treatment responses in heart failure with reduced ejection fraction	8
The prognostic significance of single-lead ST-segment resolution in ST-segment elevation myocardial infarction patients treated with primary PCI – A substudy of the randomized TOTAL trial	8
Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease	8
Computerized clinical decision support to improve stroke prevention therapy in primary care management of atrial fibrillation: a cluster randomized trial	8
Prevalence and clinical correlates and characteristics of “Super Fontan”	8
Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension – the SaltSwitch Online Grocery Shopping randomized trial	8
Table of Contents	8
Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial	8
The pathophysiology of patent foramen ovale and its related complications	8
Information for Readers	8
Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE)	8
Patient characteristics and long-term outcomes in patients undergoing transcatheter aortic valve implantation in a failed surgical prosthesis vs in a native valve: A Danish nationwide study	8
Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2)	8
Study design for an emulated trial of a 2 arm, parallel, stratified, adaptive, RCT of CABG versus PCI in people requiring myocardial revascularization at high risk (High-Risk REVASC)	8
The contemporary cardio-obstetrics team: The path to improving maternal outcomes in high-risk patients	8
Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation	8
Caribbean and South American team-based strategy to control hypertension (CATCH): Rationale and study design of a cluster randomized trial	8
Hidden in Plain Sight: The Association of Cystic Fibrosis and Diabetic Ketoacidosis- A Nationwide Study	8
Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry	8
Characterization of peripheral artery disease and associations with traditional risk factors, mobility, and biomarkers in the project baseline health study	8
Medicare coverage gap status, adherence to oral anticoagulation, and stroke rates in patients with atrial fibrillation	8
MAFLD and Cardiovascular Disease Risk Assessment in the Primary Care Setting	8
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design	8
Information for Readers	8
Biomarkers in Determining the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Hypertension	8
The coronary microvascular angina cardiovascular magnetic resonance imaging trial: Rationale and design	8
Discontinuation of SGLT-2i and GLP-1RA among persons with Type 2 diabetes and atherosclerotic cardiovascular disease treated in US cardiology clinics	8
Quality and rapidity of anticoagulation in patients with acute pulmonary embolism undergoing mechanical thrombectomy	8
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation	8
The randomized controlled trial to compare temporary permanent pacemaker vs temporary pacemaker in patients with conduction block after transcatheter aortic valve replacement: Rationale and design of	8
Editorial Board	8
Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): Randomized, placebo-controlled	8
Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial	8
Table of Contents	8
Novel automated electronic medical record-based VEST (virtual echocardiography screening tool) algorithm for pulmonary arterial hypertension	8
Relationship between industry payments to physicians and prescription patterns for PCSK9is, ARNis and DOACs: A report from the NCDR PINNACLE registry	7
Incremental cost of complications after TAVR and SAVR in contemporary clinical practice	7
Evaluation, Treatment, and Outcomes in Patients With Possible Severe Aortic Stenosis	7
at onal anish endocarditis st die – Design and objectives of the NIDUS registry	7
Microalbuminuria in Patients with Type 2 Diabetes Mellitus Treated with a Phytoformula as Adjuvant.	7
Association of sex with in-hospital management and outcomes of patients with heart failure: Data from the REAL-HF registry	7
Pulsed field ablation-related hemoglobinuria and acute kidney injury: Insights and strategies for effective management	7
Prognosis of elderly non-valvular atrial fibrillation patients stratified by B-type natriuretic peptide: ELDERCARE-AF subanalysis	7